Intra Cellular Therapies



Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 22.24M 10.04M 2025-03
ALKERMES USD 21.21M 142.21M 2025-03
Biogen USD 754.8M 7.2M 2024-12
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Cytokinetics USD -153331000 16.67M 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
Halozyme Therapeutics USD 162M 33.97M 2025-03
J&J USD 7.88B 1.76B 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Prothena USD -64676000 1.61M 2024-12
RedHill Biopharma USD 2.69M 108.46M 2023-06
Supernus Pharmaceuticals USD 49.15M 11.8M 2024-12
United Therapeutics USD 402.6M 19.2M 2025-03



Intra Cellular Therapies - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.